Mycobacterium Avium Clinical Trials

8 recruitingLast updated: May 13, 2026

There are 8 actively recruiting mycobacterium avium clinical trials across 11 countries. Studies span Phase 4, Phase 2. Top locations include Beijing, Beijing Municipality, China, Nanchang, Jiangxi, China, Nijmegen, Netherlands. Updated daily from ClinicalTrials.gov.


Mycobacterium Avium Trials at a Glance

8 actively recruiting trials for mycobacterium avium are listed on ClinicalTrialsFinder across 6 cities in 11 countries. The largest study group is Phase 4 with 4 trials, with the heaviest enrollment activity in Beijing, Nanchang, and Nijmegen. Lead sponsors running mycobacterium avium studies include Bin Cao, Radboud University Medical Center, and Shanghai Pulmonary Hospital, Shanghai, China.

Browse mycobacterium avium trials by phase

Treatments under study

About Mycobacterium Avium Clinical Trials

Looking for clinical trials for Mycobacterium Avium? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Mycobacterium Avium trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Mycobacterium Avium clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 2

Safety, Immunogenicity, and Efficacy of Therapeutic Mycobacterium Bovis BCG (BOOST)

Mycobacterium Infections, NontuberculousMycobacterium Avium-Intracellulare Infection
University of Virginia48 enrolled1 locationNCT07094711
Recruiting
Phase 4

Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary Disease

Mycobacterium Avium Complex Pulmonary Disease
Bin Cao188 enrolled6 locationsNCT07213765
Recruiting
Phase 4

Short-term Bactericidal Effect of Contezolid in MAC-PD

Mycobacterium Avium Complex Pulmonary Disease
Bin Cao188 enrolled3 locationsNCT07084402
Recruiting
Phase 4

Prevention of Recurrence With Cordyceps Sinensis in Mycobacterium Avium Complex Pulmonary Disease

Mycobacterium Avium Complex Pulmonary Disease
Bin Cao300 enrolled6 locationsNCT07174076
Recruiting
Phase 4

Hypertonic Saline Inhalation for Mycobacterium Avium Complex Pulmonary Disease

Nontuberculous Mycobacterial Lung DiseaseMycobacterium Avium Complex
Radboud University Medical Center30 enrolled1 locationNCT05192057
Recruiting

A Prospective, Multicenter, Single-arm MAC-PD Cohort: a NTM-NET and ESGMYC Collaborative Study

Mycobacterium Avium Complex Pulmonary Disease
Radboud University Medical Center100 enrolled11 locationsNCT05906316
Recruiting

M. Avium WGS During Mav-PD Treatment

Respiratory Tract DiseasesMycobacterium AviumMycobacterium Infections, Nontuberculous+2 more
University Health Network, Toronto40 enrolled1 locationNCT06266442
Recruiting

Drug Exposure and Minimum Inhibitory Concentration in the Treatment of MAC Lung Disease

Mycobacterium InfectionsGram-Positive Bacterial InfectionsMycobacterium Avium Complex+1 more
Shanghai Pulmonary Hospital, Shanghai, China100 enrolled1 locationNCT05824988